AAV Mediated Expression of Activated Factor V (FVa) for Hemophilia

被引：0
|
作者：
Sun, Junjiang [1 ,2 ]
Chai, Zheng [1 ]
Chen, Xiaojin [1 ]
Ralph, Taylor [1 ]
Nichols, Timothy C. [3 ]
Li, Chengwen [1 ]
机构：
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA
[3] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
943
引用
收藏
页码：410 / 411
页数：2
相关论文
共 50 条
  • [41] Stable Factor IX Activity Following AAV-mediated Gene Transfer in Patients with Severe Hemophilia B.
    Nathwani, Amit
    HUMAN GENE THERAPY, 2012, 23 (10) : A16 - A16
  • [42] Verification of functional AAV-mediated neurotrophic and anti-apoptotic factor expression
    Kells, Adrian P.
    Henry, Rebecca A.
    Hughes, Stephanie M.
    Connor, Bronwen
    JOURNAL OF NEUROSCIENCE METHODS, 2007, 161 (02) : 291 - 300
  • [43] AAV5-Factor VIII Gene Transfer in Severe Hemophilia A
    Rangarajan, Savita
    Walsh, Liron
    Lester, Will
    Perry, David
    Madan, Bella
    Laffan, Michael
    Yu, Hua
    Vettermann, Christian
    Pierce, Glenn F.
    Wong, Wing Y.
    Pasi, K. John
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2519 - 2530
  • [44] Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V
    Thorelli, E
    Kaufman, RJ
    Dahlbäck, B
    BLOOD, 1999, 93 (08) : 2552 - 2558
  • [45] Induction of Immune Tolerance to Canine FVIII in Hemophilia a Dogs with Inhibitors Using AAV-Mediated Expression of Canine FVIII
    Finn, Jonathan D.
    Sabatino, Denise E.
    Ozelo, Margareth C.
    Zhou, Shangzhen
    Lillicrap, David
    Kazazian, Haig H.
    Nichols, Timothy C.
    Arruda, Valder R.
    BLOOD, 2008, 112 (11) : 96 - 96
  • [46] The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
    Shen Youjin
    Yin Jun
    BIOTECHNOLOGY LETTERS, 2009, 31 (03) : CP7 - CP14
  • [47] The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy
    Shen Youjin
    Yin Jun
    Biotechnology Letters, 2009, 31 : 321 - 328
  • [48] AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects
    Hasbrouck, N. C.
    High, K. A.
    GENE THERAPY, 2008, 15 (11) : 870 - 875
  • [49] AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects
    N C Hasbrouck
    K A High
    Gene Therapy, 2008, 15 : 870 - 875
  • [50] Human Factor VIII Expression and Normalization of Bleeding Following AAV Gene Therapy in a Double Knockout Mouse Model of Hemophilia
    Bunting, Stuart
    Zhang, Lening
    Xie, Lin
    Bullens, Sherry
    Mahimkar, Rajeev
    Fong, Sylvia
    Sandza, Krystal
    Colosi, Peter
    Long, Shinong
    Vehar, Gordon Allen
    Carter, Barrie
    BLOOD, 2015, 126 (23)
12345